文献速递心力衰竭与心肌病

非 compaction 心肌病的遗传学、临床特征与长期结局

Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy.
PubMed 文献 · J Am Coll Cardiol · 2018-01-01

该回顾性多中心研究将 327 例无亲缘关系的 NCCM 患者分为遗传性(32%)、可能遗传性(16%)和散发性(52%),发现 MYH7、MYBPC3 和 TTN 突变最常见,遗传性患者左室收缩功能不全风险更高,且儿童突变频率更高并与 MACE 相关。

要点

  • NCCM 患者中 32% 携带突变,MYH7、MYBPC3 和 TTN 突变占 71%。
  • 遗传性患者左室收缩功能不全风险高于可能遗传性和散发性(p=0.024)。
  • 儿童突变更常见(p=0.04)且与 MACE 相关(p=0.025)。

核心结论

  • NCCM 是异质性疾病,遗传分层有助于临床管理,区分遗传性与非遗传性 NCCM 可补充结局预测并指导随访。

研究设计与样本

  • 荷兰 4 个心脏遗传中心回顾性多中心研究,纳入 327 例无亲缘关系的 NCCM 患者(成人及儿童)。

主要发现

  • 遗传性患者 81 例成人、23 例儿童;可能遗传性 45 例成人、8 例儿童;散发性 149 例成人、21 例儿童。
  • MYH7、MYBPC3 和 TTN 突变占遗传性 NCCM 的 71%。
  • 遗传性患者左室收缩功能不全风险高于可能遗传性和散发性(p=0.024),多突变和 TTN 突变者风险最高。
  • 儿童突变更常见(p=0.04)且与 MACE 相关(p=0.025)。
  • MYH7 突变患者 MACE 风险低(p=0.03)。

临床怎么用

  • 对 NCCM 患者进行基因检测和家系筛查,区分遗传性与散发性以指导随访强度。
  • 携带突变者需重点监测左室收缩功能,儿童突变携带者尤需关注 MACE 风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The clinical outcomes of noncompaction cardiomyopathy (NCCM) range from asymptomatic to heart failure, arrhythmias, and sudden cardiac death. Genetics play an important role in NCCM. OBJECTIVES: This study investigated the correlations among genetics, clinical features, and outcomes in adults and children diagnosed with NCCM. METHODS: A retrospective multicenter study from 4 cardiogenetic centers in the Netherlands classified 327 unrelated NCCM patients into 3 categories: 1) genetic, with a mutation in 32% (81 adults; 23 children) of patients; 2) probably genetic, familial cardiomyopathy without a mutation in 16% (45 adults; 8 children) of patients; or 3) sporadic, no family history, without mutation in 52% (149 adults; 21 children) of patients. Clinical features and major adverse cardiac events (MACE) during follow-up were compared across the children and adults. RESULTS: MYH7, MYBPC3, and TTN mutations were the most common mutations (71%) found in genetic NCCM. The risk of having reduced left ventricular (LV) systolic dysfunction was higher for genetic patients compared with the probably genetic and sporadic cases (p = 0.024), with the highest risk in patients with multiple mutations and TTN mutations. Mutations were more frequent in children (p = 0.04) and were associated with MACE (p = 0.025). Adults were more likely to have sporadic NCCM. High risk for cardiac events in children and adults was related to LV systolic dysfunction in mutation carriers, but not in sporadic cases. Patients with MYH7 mutations had low risk for MACE (p = 0.03). CONCLUSIONS: NCCM is a heterogeneous condition, and genetic stratification has a role in clinical care. Distinguishing genetic from nongenetic NCCM complements prediction of outcome and may lead to management and follow-up tailored to genetic status.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. van Waning JI, Caliskan K, Hoedemaekers YM, et al. Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy. J Am Coll Cardiol. 2018. PMID: 29447731. doi:10.1016/j.jacc.2017.12.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。